Anthracimycin
Anthracimycin is an aminoacyl-tRNA synthetase inhibitor. Anthracimycin exhibits in vitro antibacterial activity against methicillin-resistant Staphylococcus aureus strains, Bacillus anthracis, and Mycobacterium tuberculosis. Anthracimycin can be used in antibacterial research[1].
Product Specifications
CAS Number
1452849-94-3
UNSPSC
12352005
Target
Bacterial
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Smiles
[H][C@@]1([C@@H](C)/C=C\C=C\[C@@H](C)OC2=O)[C@@](C(CC([C@H]2C)=O)=O)([H])[C@]3([H])[C@]([H])(CC(C)=CC3)C=C1
Molecular Formula
C25H32O4
Molecular Weight
396.52
References & Citations
[1]Tian P, et al. Ten-step asymmetric total syntheses of potent antibiotics anthracimycin and anthracimycin B. Chem Sci. 2022 Oct 15;13 (43) :12776-12781.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
More Discoveries
Explore Other Products
Browse additional items from our catalog
406334-01 50 µL
DCXR (L-Xylulose Reductase, XR, Carbonyl Reductase II, Dicarbonyl/L-Xylulose Reductase, Kidney Dicarbonyl Reductase, kiDCR, Short Chain Dehydrogenase/Reductase Family 20C Member 1, Sperm Surface Protein P34H, SDR20C1)
Sign In for Pricing
View Details 
406334-02 100 µL
DCXR (L-Xylulose Reductase, XR, Carbonyl Reductase II, Dicarbonyl/L-Xylulose Reductase, Kidney Dicarbonyl Reductase, kiDCR, Short Chain Dehydrogenase/Reductase Family 20C Member 1, Sperm Surface Protein P34H, SDR20C1)
Sign In for Pricing
View Details 
035051-ML650 100 µL
ELOVL5, CT (ELOVL5, ELOVL2, Elongation of very long chain fatty acids protein 5, 3-keto acyl-CoA synthase ELOVL5, ELOVL fatty acid elongase 5, Fatty acid elongase 1) (MaxLight 650) discontinued
Sign In for Pricing
View Details 